Synergistic effects of simvastatin and bone marrow-derived mesenchymal stem cells on hepatic fibrosis

MLA

Soon Koo Baik, et al. “Synergistic Effects of Simvastatin and Bone Marrow-Derived Mesenchymal Stem Cells on Hepatic Fibrosis.” Biochemical and Biophysical Research Communications, vol. 497, Feb. 2018, pp. 264–71. EBSCOhost, https://doi.org/10.1016/j.bbrc.2018.02.067.

APA

Soon Koo Baik, Sung Hoon Kim, Kyung Sik Kim, Yoon Ok Jang, Moon Young Kim, Sei Jin Chang, Seung Kuy Cha, Kyu Sang Park, & Mee Yon Cho. (2018). Synergistic effects of simvastatin and bone marrow-derived mesenchymal stem cells on hepatic fibrosis. Biochemical and Biophysical Research Communications, 497, 264–271. https://doi.org/10.1016/j.bbrc.2018.02.067

Chicago

Soon Koo Baik, Sung Hoon Kim, Kyung Sik Kim, Yoon Ok Jang, Moon Young Kim, Sei Jin Chang, Seung Kuy Cha, Kyu Sang Park, and Mee Yon Cho. 2018. “Synergistic Effects of Simvastatin and Bone Marrow-Derived Mesenchymal Stem Cells on Hepatic Fibrosis.” Biochemical and Biophysical Research Communications 497 (February): 264–71. doi:10.1016/j.bbrc.2018.02.067.